IP Library Granted Patent US 6,924,123
Granted Patent B2
US 6,924,123 · App. 10/324,616 · Granted Aug 2, 2005

Lentiviral LTR-deleted vector

Assignee: Oxford BioMedica (UK) Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,924,123
App. No.
10/324,616
Granted
Aug 2, 2005
Kind
B2
Abstract

A vector capable of transducing non-dividing and/or slowly dividing cells is provided, wherein the vector is a lentiviral LTR-deleted vector. Also provided is a method for producing a protein of interest in a non-dividing or slowly dividing cell by transducing the cell with a lentiviral LTR-deleted vector and expressing the protein of interest in the cell. In addition, target cells containing the lentiviral LTR-deleted vector are provided.

Claims (8)

1. A lentiviral vector particle capable of transducing a non-dividing or slowly-dividing cell, said vector particle comprising a lentiviral LTR-deleted (LCD) vector, wherein the LLD vector comprises sequences sufficient for reverse transcription and integration, and wherein, upon transduction, the LLD vector comprises a non-functional lentiviral 5′ LTR promoter.

2. The vector particle according to claim 1 , further comprising a nucleotide sequence of interest (NOI).

3. A method for producing a protein of interest in a non-dividing or slowly-dividing cell, comprising the steps of:

a) transducing the cell with the vector particle according to claim 2 , wherein the NOI encodes a protein of interest; and

b) expressing the protein of interest in the cell.

4. The method according to claim 3 , wherein the non-dividing cell is a neuron.

5. A target cell in vitro comprising the vector particle of claim 1 .

6. A target cell in vitro comprising the vector particle of claim 2 .

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 11, 2017
From: OBERLAND CAPITAL SA LLC
To: OXFORD BIOMEDICA (UK) LIMITED
Reel/Frame 042975/0446 →
SECURITY INTEREST Recorded Jun 22, 2015
From: OXFORD BIOMEDICA (UK) LIMITED
To: OBERLAND CAPITAL SA LLC
Reel/Frame 035993/0501 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DOCUMENT DATE PREVIOUSLY RECORDED ON REEL 013689 FRAME 0945. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Jan 31, 2007
From: KINGSMAN, ALAN J.; KINGSMAN, SUSAN M.
To: OXFORD BIOMEDICA (UK) LIMITED
Reel/Frame 018828/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2003
From: KINGSMAN, ALAN J.; KINGSMAN, SUSAN MARY
To: OXFORD BIOMEDICA (UK) LIMITED
Reel/Frame 013689/0945 →
Priority Claims (1)
GB 9622500 · Oct 29, 1996 · national
Continuity (2)
Continuation In Part 0925483200
Related Publication 20030113920A1 · Jun 19, 2003